US Broker Ratings

Qiagen N.V. (QGEN) Investor Outlook: Analyzing Growth Potential with an 8.24% Upside

For investors interested in the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents an intriguing opportunity with its current market dynamics and potential upside. Headquartered in Venlo,..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 16.52% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the global pharmaceutical landscape, commands a significant presence in the healthcare sector, particularly in the arena of..

Molina Healthcare Inc (MOH) Stock Analysis: Evaluating a 6.45% Potential Upside with Market Dynamics

Molina Healthcare Inc (MOH) stands as a prominent player in the healthcare sector, focusing on providing managed healthcare services to low-income families and individuals. With a..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 21.77% Potential Upside in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, stands out as an intriguing investment opportunity for those focused on the drug manufacturing..

The Cooper Companies, Inc. (COO): Investor Outlook with a 9.41% Potential Upside

For investors looking to explore opportunities in the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling case with a potential upside of 9.41%...

Humana Inc. (HUM) Stock Analysis: Evaluating Growth Potential with a 8.16% Upside

Investors eyeing opportunities in the healthcare sector may want to give Humana Inc. (NYSE: HUM) a closer look. With a market capitalization of $46.23 billion, Humana..

Labcorp Holdings Inc. (LH) Stock Analysis: A Strong Buy with 5.82% Upside Potential and Robust Growth Prospects

Labcorp Holdings Inc. (NYSE: LH), a leading player in the healthcare sector, stands out with its focus on diagnostics and research. Based in Burlington, North Carolina,..

Genmab A/S (GMAB) Stock Analysis: Promising 23% Upside Potential with Strong Buy Ratings

Genmab A/S (NASDAQ: GMAB), a leading biotechnology firm based in Denmark, is making waves in the healthcare sector with its innovative approach to antibody-based treatments. With..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Its 5.11% Potential Upside

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector with a market capitalization of $624.74 billion, has long been a staple in many investment..

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 20% Potential Upside Amid Strong Revenue Growth

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, particularly within the medical care facilities industry, presents a compelling investment opportunity for..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Growth Amidst a High Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP) continues to capture investor attention with its robust performance in the healthcare sector, specifically within the Diagnostics & Research industry. The..

DaVita Inc. (DVA) Stock Analysis: Strong Upside Potential with an 18.86% Gain on the Horizon

DaVita Inc. (NYSE: DVA), a leading player in the healthcare sector specializing in kidney dialysis services, is presenting a compelling opportunity for investors with its robust..

Medtronic plc (MDT) Stock Analysis: Unpacking a 12.94% Potential Upside with Strong Buy Ratings

Medtronic plc (NYSE: MDT), a global leader in medical devices, presents an intriguing opportunity for investors seeking stability and growth in the healthcare sector. Headquartered in..

Tempus AI, Inc. (TEM) Stock Analysis: 20.35% Potential Upside Amid Strong Revenue Growth

In the evolving landscape of healthcare technology, Tempus AI, Inc. (NASDAQ: TEM) stands out as a significant player, capturing investor interest with its innovative approach and..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 25.99% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a titan in the healthcare sector, continues to attract investor attention with its cutting-edge medical instruments and promising financial outlook. Headquartered..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring Growth Potential and Dividend Stability

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is catching the eye of investors with its robust growth potential and reliable dividend..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a Potential 18.16% Upside with Robust Pipeline and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD) remains a compelling subject for investors interested in the healthcare sector, particularly in the realm of drug manufacturing. With a market..

Koninklijke Philips N.V. NY Reg (PHG): Analyst Ratings Suggest 20.50% Upside Potential

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare sector, continues to capture the attention of investors with its resilient performance and promising potential..

Solventum Corporation (SOLV) Stock Analysis: Exploring Potential Upside with a 13.19% Gain Insight

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is making waves in the investment community with its compelling market position and strategic business..

Danaher Corporation (DHR) Stock Analysis: A Healthcare Giant with 11.33% Upside Potential

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, is capturing investor attention with a compelling potential upside of 11.33%, as highlighted by recent analyst..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds